Benha University
Banhā, Al Qalyoubia, 13511, Egypt
NCT Number: NCT07356219
Coronary artery bypass grafting (CABG) is a major cardiac surgery associated with risks of serious perioperative complications and mortality. Malnutrition and inflammation are known independent risk factors for poor outcomes in patients with coronary artery disease. This retrospective observational study evaluates the Prognostic Nutritional Index (PNI)-a simple score derived from serum albumin and lymphocyte counts-as an objective measure of nutritional and inflammatory status. The research aims to determine how well preoperative PNI and its postoperative changes can predict complications such as acute kidney injury, myocardial infarction, and sternal wound infections in patients undergoing CABG.
This study is active but is not currently recruiting participants.
Notify Me25 year–55 year
All sexes
Observational
Banhā, Al Qalyoubia, 13511, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Calculated using serum albumin (g/L) and total peripheral lymphocyte count.
Calculated from peripheral blood counts.
Calculated from preoperative weight and height.
Time frame: Approximately 30 days (From surgery through the duration of the hospital/ICU stay.)
The Area Under the Receiver Operating Characteristic (ROC) Curve (AUC) used to determine the performance of the PNI score in predicting the occurrence of major postoperative complications.
Benha University
Other
The Merits of the Prognostic Nutritional Index for Prediction of the Outcome of Coronary Artery Bypass Grafting Surgery: A Retrospective Observational Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05755711
Arterial Occlusive Diseases, Arteriosclerosis
Loma Linda, California, United States
View Trial DetailsNCT06885177
Arterial Occlusive Diseases, Arteriosclerosis
Scottsdale, Arizona, United States
View Trial DetailsNCT04763200
Anterior Wall Myocardial Infarction, Arterial Occlusive Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT04470934
Arterial Occlusive Diseases, Arteriosclerosis
Jena, Thuringia, Germany
View Trial Details